Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6757)
All Articles published online
|
Publishing Process of This Article
|
Feb 21, 2015 (publication date) through Jan 30, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shimizu M, Furusyo N, Ikezaki H, Ogawa E, Hayashi T, Ihara T, Harada Y, Toyoda K, Murata M, Hayashi J. Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B. World J Gastroenterol 2015; 21(7): 2116-2123 [PMID: 25717246 DOI: 10.3748/wjg.v21.i7.2116] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i7/2116.htm |
| Number | Citing Articles |
| 1 |
Bingbing Hou, Changming Lin, Zongyao Hao. Chronic hepatitis B virus infection increases the risk of upper urinary calculi. BMC Urology 2022; 22(1) doi: 10.1186/s12894-022-01038-z
|
| 2 |
Ziyue Li, Chuan Shen, Yadong Wang, Wei Wang, Qian Zhao, Zhenzhong Liu, Yang Wang, Caiyan Zhao. Circulating kidney injury molecule-1 is a novel diagnostic biomarker for renal dysfunction during long-term adefovir therapy in chronic hepatitis B. Medicine 2016; 95(44): e5264 doi: 10.1097/MD.0000000000005264
|
| 3 |
Linli Sun, Dan Yi, Wei Sun, Chunjiang Wang. Retrospective analysis of the clinical characteristics of adefovir dipivoxil–induced Fanconi’s syndrome in the Chinese population. Journal of Clinical Pharmacy and Therapeutics 2020; 45(4): 722 doi: 10.1111/jcpt.13154
|
| 4 |
Sébastien Redant, David De Bels, Patrick M. Honoré. Severe Acute Respiratory Syndrome Coronavirus-2-Associated Acute Kidney Injury: A Narrative Review Focused Upon Pathophysiology. Critical Care Medicine 2021; 49(5): e533 doi: 10.1097/CCM.0000000000004889
|
| 5 |
Abhasnee Sobhonslidsuk, Pawin Numthavaj, Jirachaya Wanichanuwat, Areepan Sophonsritsuk, Supanna Petraksa, Alongkorn Pugasub, Paisan Jittorntam, Anucha Kongsomgan, Sittiruk Roytrakul, Bunyong Phakdeekitcharoen. Reversal of Proximal Renal Tubular Dysfunction after Nucleotide Analogue Withdrawal in Chronic Hepatitis B. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/4327385
|
| 6 |
Angelika Janaszkiewicz, Ágota Tóth, Quentin Faucher, Hélène Arnion, Nicolas Védrenne, Chantal Barin-Le Guellec, Pierre Marquet, Florent Di Meo. Substrate binding and lipid-mediated allostery in the human organic anion transporter 1 at the atomic-scale. Biomedicine & Pharmacotherapy 2023; 160: 114342 doi: 10.1016/j.biopha.2023.114342
|
| 7 |
Makoto Nakamuta. IV. Treatment for Hepatitis or Liver Cirrhosis in Patients with CKD. Nihon Naika Gakkai Zasshi 2017; 106(5): 936 doi: 10.2169/naika.106.936
|
| 8 |
Sobia Manzoor, Muhammad Saalim, Muhammad Imran, Saleha Resham, Javed Ashraf. Hepatitis B virus therapy: What’s the future holding for us?. World Journal of Gastroenterology 2015; 21(44): 12558-12575 doi: 10.3748/wjg.v21.i44.12558
|
| 9 |
Kaixin Song, Qi Yan, Yi Yang, Mengyue Lv, Yuting Chen, Yue Dai, Le Zhang, Yi Huang, Cuntai Zhang, Hongyu Gao. Fanconi syndrome induced by adefovir dipivoxil: a case report and clinical review. Journal of International Medical Research 2020; 48(10) doi: 10.1177/0300060520954713
|
| 10 |
Zhouqi Tang, Tengfang Li, Helong Dai, Chen Feng, Xubiao Xie, Fenghua Peng, Gongbin Lan, Shaojie Yu, Yu Wang, Chunhua Fang, Manhua Nie, Xiaoqiong Yuan, Xiaotian Tang, Xin Jiang, Xuejing Zhu, Yuxi Fan, Jiawei Peng, Siyu Sun, Mingda Zhong, Hedong Zhang, Longkai Peng. Drug-induced Fanconi syndrome in patients with kidney allograft transplantation. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.979983
|
| 11 |
Tatsuo Yamamoto, Yasuhiko Maruyama, Naro Ohashi, Hideo Yasuda, Masami Shinozaki. Hypophosphatemia predicts a failure to recover from adefovir‐related renal injury after dose reduction in lamivudine‐resistant hepatitis B patients. Hepatology Research 2017; 47(12): 1272 doi: 10.1111/hepr.12865
|
| 12 |
Blessy George, Dahea You, Melanie S. Joy, Lauren M. Aleksunes. Xenobiotic transporters and kidney injury. Advanced Drug Delivery Reviews 2017; 116: 73 doi: 10.1016/j.addr.2017.01.005
|
| 13 |
Nese Inan, Fehmi Tabak. Viral Hepatitis: Chronic Hepatitis B. 2018; : 71 doi: 10.1007/978-3-319-93449-5_7
|
| 14 |
Ryo Koda, Masafumi Tsuchida, Noriaki Iino, Ichiei Narita. Hypophosphatemic Osteomalacia Associated with Adefovir-induced Fanconi Syndrome Initially Diagnosed as Diabetic Kidney Disease and Vitamin D Deficiency. Internal Medicine 2019; 58(6): 821 doi: 10.2169/internalmedicine.1698-18
|
| 15 |
Yong Lin, Fan Pan, Yingchao Wang, Ziqian Chen, Chun Lin, Lvfeng Yao, Xin Zhang, Rui Zhou, Chen Pan. Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: A study of 28 cases. Oncology Letters 2017; 13(1): 307 doi: 10.3892/ol.2016.5393
|
| 16 |
Nan Chen, Jian-bo Zhang, Qiujie Zhang, Yun-peng Zhao, Li-yan Li, Li-wei Liu, Fei Yu, Xin Yu, Tao Peng, Kuan-xiao Tang. Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series. BMC Pharmacology and Toxicology 2018; 19(1) doi: 10.1186/s40360-018-0212-7
|